PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAG PREMIX
- 专利权人:
- 发明人:
- RAO DHARMARAJ RAMACHANDRA,MALHOTRA GEENA,PATHI SRINIVAS LAXMINARAYAN,PUPPALA RAVIKUMAR,KOMMULA NARAYANASWAMI
- 申请号:
- IN201621036949
- 公开号:
- IN201621036949A
- 申请日:
- 2016.10.27
- 申请国别(地区):
- IN
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention is directed to novel solid state forms of selexipag, including an amorphous form of selexipag and a selexipag- containing premix, to methods for their preparation, to pharmaceutical compositions comprising them and to their use in medicine, particularly for the treatment of pulmonary arterial hypertension.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- RÉGIME POSOLOGIQUE ET MÉTHODE DE TRAITEMENT DE L'HYPERTENSION ARTÉRIELLE PULMONAIRE PAR RODATRISTAT ÉTHYLE
- METHOD FOR ASSESSING EFFICACY OF S-ATENOLOL IN TREATMENT OF ISCHEMIC HEART DISEASE WITH ANGINA AND ARTERIAL HYPERTENSION WITH HYPERTROPHIC TYPE OF IMPAIRED DIASTOLIC FUNCTION OF LEFT VENTRICLE
- METHOD FOR ASSESSING EFFICACY OF ATORVASTATIN IN TREATING ISCHEMIC HEART DISEASE WITH ANGINA PECTORIS AND ARTERIAL HYPERTENSION
- METHOD FOR ASSESSING EFFICACY OF S-METOPROLOL IN TREATMENT OF ISCHEMIC HEART DISEASE WITH ANGINA AND ARTERIAL HYPERTENSION WITH HYPERTROPHIC TYPE OF IMPAIRED DIASTOLIC FUNCTION OF LEFT VENTRICLE
- METHOD FOR ASSESSING EFFICACY OF ATORVASTATIN IN TREATING ISCHEMIC HEART DISEASE WITH ANGINA PECTORIS AND ARTERIAL HYPERTENSION WITH IMPAIRMENT OF DIASTOLIC FUNCTION OF LEFT VENTRICLE ACCORDING TO HYPERTROPHIC TYPE